2012|13 Annual Report Fraunhofer IGB

4 6 0 M E D I C I N E 62 Biomimetic, antibacterial bone implants for the prevention of local infections 64 Human 3D lung tumor model 66 Developing biologically inspired cardiovascular regenerative technologies 68 Innovative cell and tissue therapies on the way into clinical application 70 Development and validation of a novel system for milk pasteurization 7 2 P H A R M A C Y 74 SKIN HEAL – a particle-based formulation for improved wound healing 76 Bioartiﬁcial proximal tubule device 78 Targeted drug delivery – RNA-mediated treatment of HSV-1 infections 80 Synthetic proteins in human pathogenic yeasts S E L E C T E D R & D R E S U L T S 2012 6 F O R E W O R D P R O F I L E 8 Brief proﬁle 9 Advisory Board of the Fraunhofer IGB 10 Services and infrastructure 12 Key ﬁgures 14 Organization chart 16 The Fraunhofer IGB’s networking activities 18 Fraunhofer groups and alliances 22 60 years Fraunhofer IGB H I G H L I G H T S 2 0 1 2 24 Projects and project groups 29 Fraunhofer IGB international 34 Strategy process at the Fraunhofer IGB 35 Appointments and prizes 36 Promoting young talents – Exhibitions 38 Pursuing sustainable goals – “Future project earth” C O M P E T E N C E S 40 Fraunhofer-Gesellschaft 42 Interfacial Engineering and Materials Science 44 Molecular Biotechnology 46 Physical Process Technology 48 Environmental Biotechnology and Bioprocess Engineering 50 Cell and Tissue Engineering 52 Fraunhofer CBP 54 Project Group BioCat 56 Project Group Oncology 58 Institute of Interfacial Process Engineering and Plasma Technology IGVP CONTENTS

2012|13 Annual Report Fraunhofer IGB

Pages